Rectal Cancer
📧 Sign up to get email alerts when something new happens for Rectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-07-16Clinical Trial Update: Optimization of Preoperative Treatment in Locally Advanced Rectal Cancer [Phase 3]
Phase 3 clinical trial update on optimizing preoperative treatment for locally advanced rectal cancer.
-
CLINICAL_TRIALS trial_result · 2021-06-21Clinical Trial Update: Durvalumab (MEDI4736) Plus Total Neoadjuvant Therapy (TNT) in Locally Advanced Rectal Cancer [Phase 2]
Phase 2 trial update evaluating durvalumab (MEDI4736) in combination with total neoadjuvant therapy for locally advanced rectal cancer.
-
CLINICAL_TRIALS trial_result · 2021-06-08Clinical Trial Update: A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk [Phase 2]
A prospective Phase II study evaluating individualized neoadjuvant chemoradiotherapy for rectal cancer based on recurrence risk.
-
CLINICAL_TRIALS trial_result · 2021-05-18Clinical Trial Update: PET-MRI in Diagnosing Patients With Colon or Rectal Cancer [NA]
Clinical trial results for PET-MRI in diagnosing recurrent colon or rectal cancer have been posted after completion.
-
CLINICAL_TRIALS trial_result · 2021-05-03Clinical Trial Update: Induction FOLFOX With or Without Aflibercept Followed by Chemoradiation in High Risk Locally Advanced Rectal Cancer [Phase 2]
Phase 2 trial evaluating induction FOLFOX with or without aflibercept followed by chemoradiation in high-risk locally advanced rectal cancer…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-04-22Clinical Trial Update: Rectal Cancer, Adjuvant Chemotherapy, FOLFOX(5-fluorouracil/Leucovorin/Oxaliplatin), Total Mesorectal Excision [Phase 2]
Phase 2 clinical trial update evaluating adjuvant FOLFOX after total mesorectal excision for locally advanced rectal cancer.
-
CLINICAL_TRIALS trial_result · 2021-04-14Clinical Trial Update: Neoadjuvant FOLFOXIRI Chemotherapy Alone for Locally Advanced Rectal Cancer [Phase 2]
Phase 2 study evaluating neoadjuvant FOLFOXIRI chemotherapy alone for locally advanced rectal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-04-14Clinical Trial Update: Totally Neoadjuvant FOLFOXIRI + Short-course Radiation + XELOX in Patients With Locally Advanced Rectal Cancer [Phase 2]
Phase 2 trial update evaluating totally neoadjuvant regimen (FOLFOXIRI + short-course radiation + XELOX) in locally advanced rectal cancer.
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: The Stockholm III Trial on Different Preoperative Radiotherapy Regimens in Rectal Cancer [NA]
A completed clinical trial assessing different preoperative radiotherapy regimens for rectal cancer; results posted in 2021. No specific eff…
-
CLINICAL_TRIALS trial_result · 2021-04-02Clinical Trial Update: Sexual Function and Wellbeing in Males With Rectal Cancer
Completed clinical trial assessing sexual function and wellbeing in males with rectal cancer; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-03-23Clinical Trial Update: A Trial of Neoadjuvant mFOLFOXIRI Versus CRT in the EMVI Positive LARC [Phase 2]
Phase 2 trial update comparing neoadjuvant mFOLFOXIRI to chemoradiation in EMVI-positive locally advanced rectal cancer.
-
CLINICAL_TRIALS trial_result · 2021-03-17Clinical Trial Update: Preoperative IMRT With Concurrent High-dose Vitamin C and mFOLFOX6 in Locally Advanced Rectal Cancer [Phase 2]
Phase 2 trial evaluating preoperative IMRT with concurrent high-dose vitamin C and mFOLFOX6 in locally advanced rectal cancer.
-
CLINICAL_TRIALS trial_result · 2021-03-12Clinical Trial Update: Pilot Randomized Evaluation of Butyrate Irrigation Before Ileostomy Closure on the Colonic Mucosa in Rectal Cancer Patients (BUTYCLO) [Phase 2]
A Phase 2 randomized pilot evaluating butyrate irrigation before ileostomy closure in rectal cancer patients; study completed.
-
CLINICAL_TRIALS trial_result · 2021-03-12Clinical Trial Update: BrUOG 302:BYL719, Capecitabine and Radiation for Rectal Cancer: A Brown University Oncology Research Group Study [Phase 1]
Phase 1 trial updating BrUOG 302 using BYL719 (alpelisib) with capecitabine and radiation for rectal cancer; trial status terminated with re…
-
CLINICAL_TRIALS trial_result · 2021-03-11Clinical Trial Update: Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer [Phase 2]
Phase II trial of the CDK inhibitor PD 0332991 (palbociclib) in various adult solid tumors including colon and breast cancers has completed …
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: Non-Operative Radiation Management of Adenocarcinoma of the Lower Rectum [Phase 2]
Phase 2 trial evaluating non-operative radiation management for adenocarcinoma of the lower rectum has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-17Clinical Trial Update: Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal Cancer [Phase 3]
Phase 3 trial update evaluating radiation therapy with capecitabine, with or without oxaliplatin, in patients undergoing surgery for stage I…
-
CLINICAL_TRIALS trial_result · 2021-02-17Clinical Trial Update: Effectiveness of Vitamin E and Hydrogen-Rich Water on Radiation Therapy-Induced Adverse In Patients With Rectal Cancer [Phase 3]
Phase 3 trial investigating the effectiveness of Vitamin E and hydrogen-rich water to reduce radiation therapy-induced adverse effects in re…
-
CLINICAL_TRIALS trial_result · 2021-02-15Clinical Trial Update: Total Neoadjuvant Therapy in Rectal Cancer Treatment [Phase 4]
Clinical trial update on total neoadjuvant therapy for rectal cancer (Phase 4).
-
CLINICAL_TRIALS trial_result · 2021-02-11Clinical Trial Update: The Role of TCM on ERAS of Rectal Cancer Patients [Phase 2]
Phase 2 trial update investigating the role of Traditional Chinese Medicine on Enhanced Recovery After Surgery in rectal cancer patients.
-
CLINICAL_TRIALS trial_result · 2021-02-09Clinical Trial Update: Induction and Consolidation Chemotherapy in Patients With Locally Advanced CRM-positive Rectal Cancer [Phase 3]
Phase 3 clinical trial evaluating induction and consolidation chemotherapy in locally advanced CRM-positive rectal cancer.
-
CLINICAL_TRIALS trial_result · 2021-02-09Clinical Trial Update: Neoadjuvant Chemotherapy in Patients With Moderate Risk Mid Rectal Cancer [Phase 3]
A Phase 3 clinical trial update examines neoadjuvant chemotherapy for patients with moderate-risk mid-rectal cancer, with status currently u…
-
CLINICAL_TRIALS trial_result · 2021-02-09Clinical Trial Update: Neoadjuvant Chemotherapy in Patients With Intermediate Risk Upper and Mid Rectal Cancer [Phase 3]
Phase 3 trial update on neoadjuvant chemotherapy for intermediate-risk upper and mid rectal cancer.
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: Bevacizumab With Pelvic Radiotherapy And Primary Chemotherapy in Patients With Poor-Risk Rectal Cancer [Phase 2]
Phase 2 trial updating bevacizumab with pelvic radiotherapy and primary chemotherapy in poor-risk rectal cancer has completed with results p…
-
CLINICAL_TRIALS trial_result · 2021-02-01Clinical Trial Update: Neoadjuvant Triplet Chemotherapy Regimen in Patients With Locally Advanced Rectal Cancer [Phase 2]
A Phase 2 clinical trial update evaluating a neoadjuvant triplet chemotherapy regimen for locally advanced rectal cancer has completed enrol…